OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

To reveal more filter options, please select whether you would like to review Active or Closed projects:

Clear
Organization: University of California - San Francisco

10 Projects | 6 Researchers | $1,173,015 Invested

2025

University of California - San Francisco

Kristine Yaffe, MD

Long-term follow-up of the Systematic Multi-domain Alzheimer's Risk Reduction Trial (SMARRT)

  • Funding Amount: $243,515
  • Organization Type:
  • Program: Prevention
  • Target: Other
  • Status: Active

2017

University of California - San Francisco

Kristine Yaffe, MD

Connection Between Depressive Symptoms and Dementia: When Best to Intervene.

  • Funding Amount: $100,000
  • Organization Type: Academic/Nonprofit
  • Program: Prevention
  • Target: Synaptic Activity and Neurotransmitters
  • Status: Closed

2015

University of California - San Francisco

Michael Weiner, MD

Brain Health Registry Trial-Ready Cohort

  • Funding Amount: $100,000
  • Organization Type: Academic/Nonprofit
  • Program: Clinical
  • Status: Closed

2011

University of California - San Francisco

William Seeley, MD

Dynamic disease-monitoring network biomarkers for tracking frontotemporal dementia

  • Funding Amount: $100,000
  • Organization Type: Academic/Nonprofit
  • Program: Biomarkers
  • Status: Closed

2011

University of California - San Francisco

Adam Boxer, MD, PhD

Biomarker Optimization for Progranulin Trials

  • Funding Amount: $75,000
  • Organization Type: Academic/Nonprofit
  • Program: Biomarkers
  • Target: Other
  • Status: Closed

2011

University of California - San Francisco

Marek Brzezinski, MD, PhD

Effects of Brain Beta-Amyloid on Postoperative Cognition

  • Funding Amount: $300,000
  • Organization Type: Academic/Nonprofit
  • Program: Prevention
  • Status: Closed

2008

University of California - San Francisco

Adam Boxer, MD, PhD

A Pilot Clinical Trial of NAP (AL-108) for Corticobasal Degeneration and Frontotemporal Lobar Degeneration with Predicted Corticobasal Degeneration Pathology

  • Funding Amount: $100,000
  • Organization Type: Academic/Nonprofit
  • Program: Clinical
  • Status: Closed

2008

University of California - San Francisco

Bruce Miller, MD

"Bridging Cultures: Improving Evaluation and Treatment of Cognitive Disorders"

  • Funding Amount: $2,000
  • Organization Type: Academic/Nonprofit
  • Program: Conferences/Other
  • Status: Closed

2006

University of California - San Francisco

Bruce Miller, MD

Fifth International Conference on Frontotemporal Dementia

  • Funding Amount: $2,500
  • Organization Type: Academic/Nonprofit
  • Program: Conferences/Other
  • Status: Closed

2000

University of California - San Francisco

Bruce Miller, MD

UCSF Investigation of the Effects of Testosterone on Cognition in Male Patients with Mild Alzheimer's Disease

  • Funding Amount: $150,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed